The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
The hCMEC/D3 cell line as a model of the human blood brain barrier
Open accessAbstract
Since the first attempts in the 1970s to isolate cerebral microvessel endothelial cells (CECs) in order to model the blood–brain barrier (BBB) in vitro , the need for a human BBB model that closely mimics the in vivo phenotype and is reproducible and easy to grow, has been widely recognized by cerebrovascular researchers in both academia and industry. While primary human CECs would ideally be the model of choice, the paucity of available fresh human cerebral tissue makes wide-scale studies impractical. The brain microvascular endothelial cell line hCMEC/D3 represents one such model of the human BBB that can be easily grown and is amenable to cellular and molecular studies on pathological and drug transport mechanisms with relevance to the central nervous system (CNS). Indeed, since the development of this cell line in 2005 over 100 studies on different aspects of cerebral endothelial biology and pharmacology have been published. Here we review the suitability of this cell line as a human BBB model for pathogenic and drug transport studies and we critically consider its advantages and limitations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Immortalized human microvascular brain endothelial (hCMEC/D3) cells were chosen as the cell line as they (i) are able to form contact-inhibited monolayers when grown on collagen type 1, a key component of the BBB basement membrane, and (ii) express tight and adherens junctions, which help regulate the structural integrity and permeability of the BBB.35,36”
From Predictive High-Throughput Platform for Dual Screening of mRNA Lipid Nanoparticle Blood–Brain Barrier Transfection and Crossing (2024) · cites this paper as [35]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Blood‐brain barrier‐specific properties of a human adult brain endothelial cell line
Weksler, B. B., Subileau, E.-A., Perrière, N., Charneau, P., Holloway, K. E., Leveque, M., Tricoire-Leignel, H., Nicotra, A., Bourdoulous, S., Turowski, P., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-3458fje · Cited by 1,325
Self-citationWnt/β-catenin signaling controls development of the blood–brain barrier
Liebner, S., Corada, M., Bangsow, T., Babbage, J., Taddei, A., Czupalla, C. J., Reis, M., Felici, A., Wolburg, H., Fruttiger, M., et al. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200806024 · Cited by 860
Derivation of blood-brain barrier endothelial cells from human pluripotent stem cells
Lippmann, E. S., Azarin, S. M., Kay, J. E., Nessler, R. A., Wilson, H. K., Al-Ahmad, A., Palecek, S. P., & Shusta, E. V. (2012) · Nature Biotechnology · doi:10.1038/nbt.2247 · Cited by 800
Electrical resistance across the blood-brain barrier in anaesthetized rats: a developmental study.
Butt, A. M., Jones, H. C., & Abbott, N. J. (1990) · The Journal of Physiology · doi:10.1113/jphysiol.1990.sp018243 · Cited by 775
Luissint, A.-C., Artus, C., Glacial, F., Ganeshamoorthy, K., & Couraud, P.-O. (2012) · Fluids and Barriers of the CNS · doi:10.1186/2045-8118-9-23 · Cited by 654
Self-citationDauchy, S., Dutheil, F., Weaver, R. J., Chassoux, F., Daumas‐Duport, C., Couraud, P., Scherrmann, J., de Waziers, I., & Declèves, X. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05720.x · Cited by 361
Self-citationHatherell, K. E., Couraud, P., Romero, I. A., Weksler, B. B., & Pilkington, G. J. (2011) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2011.05.012 · Cited by 358
Self-citationPoller, B., Gutmann, H., Krähenbühl, S., Weksler, B. B., Romero, I. A., Couraud, P., Tuffin, G., Drewe, J., & Huwyler, J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05730.x · Cited by 318
Self-citationFörster, C. Y., Burek, M., Romero, I. A., Weksler, B. B., Couraud, P., & Drenckhahn, D. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2007.146852 · Cited by 306
Self-citationCucullo, L., Couraud, P., Weksler, B. B., Romero, I. A., Hossain, M. K., Rapp, E., & Janigro, D. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600525 · Cited by 266
Self-citation
Research works printed but not linked: 1
- Lopez-Ramirez MA, Fischer R, Torres-Badillo CC, Davies HA, Logan K, Pfizenmaier K, Male DK, Sharrack B, Romero IA: Role of caspases in cytokine-induced barrier breakdown in human brain endothelial cells. J Immunol. 2012, 189: 3130-3139. 10.4049/jimmunol.1103460. · DOI
Cited by
Sorted by citations
Items 201–300 of 754
Gerhartl, A., Pracser, N., Vladetic, A., Hendrikx, S., Friedl, H.-P., & Neuhaus, W. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00179-3 · Cited by 43
Veiga-Matos, J., Morales, A. I., Prieto, M., Remião, F., & Silva, R. V. D. S. (2023) · Molecules · doi:10.3390/molecules28227532 · Cited by 46
Ureña-Vacas, I., Belén, A. D. L. R. M., Serrano, D. R., & González‐Burgos, E. (2024) · Current Research in Biotechnology · doi:10.1016/j.crbiot.2024.100235 · Cited by 41
Emerging Biomimetic Drug Delivery Nanoparticles Inspired by Extracellular Vesicles
Sundaram, V., & Aryal, S. (2025) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.70025 · Cited by 44
Cox, A., Vinciguerra, D., Re, F., Magro, R. D., Mura, S., Masserini, M., Couvreur, P., & Nicolas, J. (2019) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2019.06.004 · Cited by 39
RAGE and CCR7 mediate the transmigration of Zika-infected monocytes through the blood-brain barrier
de Carvalho, G. C., Borget, M.-Y., Bernier, S., Garneau, D., Duarte, A. J. D. S., & Dumais, N. (2019) · Immunobiology · doi:10.1016/j.imbio.2019.08.007 · Cited by 39
Gericke, B., Römermann, K., Noack, A., Noack, S., Kronenberg, J., Blasig, I. E., & Löscher, W. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00212-5 · Cited by 40
The TNFR1 Antagonist Atrosimab Is Therapeutic in Mouse Models of Acute and Chronic Inflammation
Richter, F., Williams, S. K., John, K., Huber, C., Vaslin, C., Zanker, H. S., Fairless, R., Pichi, K., Marhenke, S., Vogel, A., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.705485 · Cited by 39
Negri, S., Faris, P. S., Maniezzi, C., Pellavio, G., Spaiardi, P., Botta, L., Laforenza, U., Biella, G. R., & Moccia, F. D. (2021) · Cell Calcium · doi:10.1016/j.ceca.2021.102454 · Cited by 41
Choublier, N., Taghi, M., Menet, M., Gall, M. L., Bruce, J., Chafey, P., Guillonneau, F., Moreau, A., Denizot, C., Parmentier, Y., et al. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-022-00344-w · Cited by 41
Self-citationEmergence of More Potent PPD-Qs beyond 6PPD-Q in Human Blood and Cerebrospinal Fluid
Han, M., Xia, K., Xue, Y., Yue, F., Li, J., Kang, F., Zhu, B., Hu, L., Liu, Q., Xie, Z., et al. (2025) · Environmental Science & Technology Letters · doi:10.1021/acs.estlett.5c00243 · Cited by 38
Gonzalez‐Carter, D., Goode, A. E., Fiammengo, R., Dunlop, I. E., Dexter, D. T., & Porter, A. E. (2016) · Journal of Neuroendocrinology · doi:10.1111/jne.12392 · Cited by 38
Vila, E., Solé, M., Masip, N., Puertas-Umbert, L., Amaro, S., Dantas, A. P., Unzeta, M., D’Ocón, P., Planas, A. M., Chamorro, Á., et al. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.04.002 · Cited by 38
Kriaučiūnaitė, K., Kaušylė, A., Pajarskienė, J., Tunaitis, V., Lim, D., Verkhratsky, A., & Pivoriūnas, A. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00871-w · Cited by 40
Synergistic induction of blood–brain barrier properties
Porkoláb, G., Mészáros, M., Szecskó, A., Vigh, J. P., Walter, F. R., de Figueiredo, R. M., Kálomista, I., Hoyk, Z., Vizsnyiczai, G., Gróf, I., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2316006121 · Cited by 37
Clofazimine functionalized polymeric nanoparticles for brain delivery in the tuberculosis treatment
de Castro, R. R., do Carmo, F. A., Martins, C., Simon, A., de Sousa, V. P., Rodrigues, C. R., Cabral, L. M., & Sarmento, B. F. C. C. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120655 · Cited by 37
Lazarevic, I., & Engelhardt, B. (2015) · Fluids and Barriers of the CNS · doi:10.1186/s12987-016-0027-0 · Cited by 36
Re-evaluation of the hCMEC/D3 based in vitro BBB model for ABC transporter studies
Balzer, V., Poc, P., Puris, E., Martin, S., Aliasgari, M., Auriola, S. O. K., & Fricker, G. (2022) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2022.02.017 · Cited by 36
Hourfar, H., Aliakbari, F., Aqdam, S. R., Nayeri, Z., Bardania, H., Otzen, D. E., & Morshedi, D. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.12.134 · Cited by 36
Inflammatory pathway interactions and cancer multidrug resistance regulation.
Mirzaei, S. A., Dinmohammadi, F., Alizadeh, A., & Elahian, F. (2019) · Life Science · doi:10.1016/j.lfs.2019.116825 · Cited by 35
In Vitro Blood–Brain Barrier-Integrated Neurological Disorder Models Using a Microfluidic Device
Choi, J., Santhosh, M., & Choi, J.-W. (2019) · Micromachines · doi:10.3390/mi11010021 · Cited by 37
Kurosawa, T., Sako, D., Tega, Y., Debori, Y., Tomihara, Y., Aoyama, K., Kubo, Y., Amano, N., & Deguchi, Y. (2022) · Pharmaceutical Research · doi:10.1007/s11095-022-03249-3 · Cited by 36
Negri, S., Scolari, F., Vismara, M., Brunetti, V., Faris, P. S., Terribile, G., Sancini, G., Berra‐Romani, R., & Moccia, F. D. (2022) · Cells · doi:10.3390/cells11233860 · Cited by 36
Okura, T., Kato, S., & Deguchi, Y. (2013) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-13-rg-058 · Cited by 36
Lab-on-a-chip models of the blood–brain barrier: evolution, problems, perspectives
Deli, M. A., Porkoláb, G., Kincses, A., Mészáros, M., Szecskó, A., Kocsis, A. E., Vigh, J. P., Valkai, S., Veszelka, S., Walter, F. R., et al. (2024) · Lab on a Chip · doi:10.1039/d3lc00996c · Cited by 35
Bhupathiraju, N. V. S. D. K., Hu, X., Zhou, Z., Fronczek, F. R., Couraud, P., Romero, I. A., Weksler, B. B., & Vicente, M. G. H. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500786c · Cited by 35
Self-citationIs RPMI 2650 a Suitable In Vitro Nasal Model for Drug Transport Studies?
Mercier, C., Perek, N., & Delavenne, X. (2017) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-017-0426-x · Cited by 37
Effects of HIV-1 Tat and Methamphetamine on Blood-Brain Barrier Integrity and FunctionIn Vitro
Patel, S., Leibrand, C. R., Palasuberniam, P., Couraud, P., Weksler, B. B., Jahr, F. M., McClay, J. L., Hauser, K. F., & McRae, M. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01307-17 · Cited by 35
Self-citationInflammation-induced TRPV4 channels exacerbate blood–brain barrier dysfunction in multiple sclerosis
Hansen, C. E., Kamermans, A., Mol, K., Berve, K., Rodriguez-Mogeda, C., Fung, W. K., Hof, B. V. H., Fontijn, R. D., van der Pol, S. M. A., Michalick, L., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03069-9 · Cited by 33
In Vitro Models of CNS Barriers
Abbott, N. J., Dolman, D. E. M., Yusof, S. R., & Reichel, A. (2013) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-1-4614-9105-7_6 · Cited by 34
Compounds Blocking Methylglyoxal-induced Protein Modification and Brain Endothelial Injury
Tóth, A. E., Tóth, A., Walter, F. R., Kiss, L., Veszelka, S., Ózsvári, B., Puskás, L. G., Heimesaat, M. M., Dohgu, S., Kataoka, Y., et al. (2014) · Archives of Medical Research · doi:10.1016/j.arcmed.2014.10.009 · Cited by 34
Colamatteo, A., Maggioli, E., Loiola, R. A., Sheikh, M. H., Calì, G., Bruzzese, D., Maniscalco, G. T., Centonze, D., Buttari, F., Lanzillo, R., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801683 · Cited by 34
Barberio, C., Withers, A. M., Mishra, Y., Couraud, P., Romero, I. A., Weksler, B. B., & Owens, R. M. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.1065193 · Cited by 38
Self-citationMora, L., & Hayes, M. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf505019z · Cited by 35
Dental, C., Proust, A. M., Ouellet, M., Barat, C., & Tremblay, M. J. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600742 · Cited by 33
Solé, M., Esteban-López, M., Taltavull, B., Fábregas, C., Fadó, R., Casals, N., Rodríguez-Álvarez, J., Miñano-Molina, A. J., & Unzeta, M. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.04.016 · Cited by 34
Bhardwaj, U., & Singh, S. K. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02548-x · Cited by 33
Kato, N., Yamada, S., Suzuki, R., Iida, Y., Matsumoto, M., Fumoto, S., Arima, H., Mukai, H., & Kawakami, S. (2023) · Drug Delivery · doi:10.1080/10717544.2023.2173333 · Cited by 33
Yang, L., Lin, Z., Mu, R., Wu, W., Zhi, H., Liu, X., Yang, H., & Liu, L. (2024) · eLife · doi:10.7554/elife.96161.3 · Cited by 34
Watson, C., Pazarentzos, E., Fidanboylu, M., Padilla, B., Brown, R. C., & Thomas, S. A. (2016) · Brain Research · doi:10.1016/j.brainres.2016.07.026 · Cited by 32
Low, Y. L., Jin, L., Morris, E. R., Pan, Y., & Nicolazzo, J. A. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b01131 · Cited by 32
Huang, J. A., Zhang, R., Wang, S., Zhang, D., Leung, C., Yang, G., Li, Y., Liu, L., Xu, Y., Lin, S., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.619436 · Cited by 32
Sreekanthreddy, P., Gromnicova, R., Davies, H. A., Phillips, J. B., Romero, I. A., & Male, D. K. (2015) · F1000Research · doi:10.12688/f1000research.7142.1 · Cited by 32
Self-citationGil, E., Venturini, C., Stirling, D. R., Turner, C. T., Tezera, L. B., Ercoli, G., Baker, T., Best, K., Brown, J., & Noursadeghi, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.935798 · Cited by 37
McCloskey, M. C., Kasap, P., Ahmad, S. D., Su, S., Chen, K., Mansouri, M., Ramesh, N., Nishihara, H., Belyaev, Y., Abhyankar, V. V., et al. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202200804 · Cited by 40
Neurovascular dysfunction in dementia – human cellular models and molecular mechanisms
Parkes, I., Chintawar, S., & Cader, M. Z. (2018) · Clinical Science · doi:10.1042/cs20160720 · Cited by 33
Hinkel, S., Mattern, K., Dietzel, A. H., Reichl, S., & Müller-Goymann, C. C. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.05.074 · Cited by 35
Wardhani, K. A., Levina, A., Grau, G. E., & Lay, P. A. (2024) · Chemical Society Reviews · doi:10.1039/d2cs00238h · Cited by 34
Endophilin-1 regulates blood-brain barrier permeability via EGFR-JNK signaling pathway
Chen, L., Liu, W., Wang, P., Xue, Y., Su, Q., Zeng, C., & Shang, X. (2015) · Brain Research · doi:10.1016/j.brainres.2015.02.032 · Cited by 31
You, D., Wen, X., Gorczyca, L., Morris, A., Richardson, J. R., & Aleksunes, L. M. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1565-7 · Cited by 31
Albekairi, T. H., Vaidya, B., Patel, R., Nozohouri, S., Villalba, H., Zhang, Y., Lee, Y. S., Al-Ahmad, A. J., & Abbruscato, T. J. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11090467 · Cited by 31
Studies of blood–brain barrier permeability of gastrodigenin in vitro and in vivo
Mi, Y., Mao, Y., Huan, C., Ke, G., Liu, M., Fang, C., & Wang, Q. (2019) · Fitoterapia · doi:10.1016/j.fitote.2019.104447 · Cited by 31
Characterization of basigin monoclonal antibodies for receptor-mediated drug delivery to the brain
Christensen, S. C., Krogh, B. O., Jensen, A. D., Andersen, C. B. F., Christensen, S., & Nielsen, M. S. (2020) · Scientific Reports · doi:10.1038/s41598-020-71286-2 · Cited by 31
Tran‐Dinh, A., Levoye, A., Couret, D., Galle-Treger, L., Moreau, M., Delbosc, S., Hoteit, C., Montravers, P., Amarenco, P., Huby, T., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010106 · Cited by 33
Syndecan-3 as a Novel Biomarker in Alzheimer’s Disease
Hudák, A., Letoha, A., Vízler, C., & Letoha, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063407 · Cited by 32
Tracking the immune response by MRI using biodegradable and ultrasensitive microprobes
de Lizarrondo, S. M., Jacqmarcq, C., Naveau, M., Navarro-Oviedo, M., Pédron, S., Adam, A., Freis, B., Allouche, S., Goux, D., Razafindrakoto, S., et al. (2022) · Science Advances · doi:10.1126/sciadv.abm3596 · Cited by 31
Curis, C., Percher, F., Jeannin, P., Montange, T., Chevalier, S. A., Seilhean, D., Cartier, L., Couraud, P., Gout, O., Gessain, A., et al. (2016) · Journal of Virology · doi:10.1128/jvi.00539-16 · Cited by 34
Self-citationZhao, W., Han, L., Bae, Y., & Manickam, D. S. (2019) · Journal of Visualized Experiments · doi:10.3791/58900 · Cited by 30
Zhao, J., Li, K., Wang, Y., Li, D., Wang, Q., Xie, S., Wang, J., & Zuo, Z. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113711 · Cited by 30
Tu, K.-H., Yu, L., Sie, Z.-H., Hsu, H.-Y., Al‐Jamal, K. T., Wang, J. T.-W., & Chiang, Y.-Y. (2020) · Micromachines · doi:10.3390/mi12010037 · Cited by 34
Império, G. E., Lye, P., Bloise, E., & Matthews, S. G. (2021) · Tissue Barriers · doi:10.1080/21688370.2020.1860616 · Cited by 30
In vitro model for predicting the access and distribution of drugs in the brain using hCMEC/D3 cells
Sánchez-Dengra, B., González‐Álvarez, I., Sousa, F., Bermejo, M., González‐Álvarez, M., & Sarmento, B. F. C. C. (2021) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2021.04.002 · Cited by 30
Cai, Y., Fan, K., Lin, J., Ma, L., & Li, F. (2022) · Micromachines · doi:10.3390/mi14010112 · Cited by 28
Shah, S., Knausenberger, T. B.-A., Pontifex, M. G., Connell, E., Gall, G. L., Hardy, T. A. J., Randall, D. W., McCafferty, K., Yaqoob, M. M., Solito, E., et al. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2431651 · Cited by 30
Yamaguchi, S., Ito, S., Hirayama‐Kurogi, M., & Ohtsuki, S. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.07.037 · Cited by 29
Bhuvanendran, S., Hanapi, N. A., Ahemad, N., Othman, I., Yusof, S. R., & Shaikh, M. F. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00495 · Cited by 29
Chrysanthou, M., Estruch, I. M., Rietjens, I. M. C. M., Wichers, H. J., & Hoppenbrouwers, T. (2022) · Nutrients · doi:10.3390/nu14020363 · Cited by 31
Piantino, M., Louis, F., Shigemoto‐Mogami, Y., Nakayama-Kitamura, K., Sato, K., Yamaguchi, T., Kawabata, K., Yamamoto, S., Iwasaki, S., Hirabayashi, H., et al. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100232 · Cited by 29
Marino, A., Battaglini, M., Carmignani, A., Pignatelli, F., Pasquale, D. D., Tricinci, O., & Ciofani, G. (2023) · APL Bioengineering · doi:10.1063/5.0155037 · Cited by 29
Volle, R., Weksler, B. B., Romero, I. A., Couraud, P., Archimbaud, C., Henquell, C., Pereira, B., Peigue‐Lafeuille, H., Bailly, J., & Mirand, A. (2015) · Journal of General Virology · doi:10.1099/vir.0.000103 · Cited by 29
Self-citationSchubert‐Unkmeir, A. (2017) · Pathogens and Disease · doi:10.1093/femspd/ftx023 · Cited by 28
Harati, R., Mabondzo, A. M., Tlili, A., Khoder, G., Mahfood, M., & Hamoudi, R. (2021) · Breast Cancer Research and Treatment · doi:10.1007/s10549-021-06255-y · Cited by 28
Advances in Modeling Alzheimer's Disease In Vitro
Sharma, N. S., Karan, A., Lee, D.-H., Yan, Z., & Xie, J. (2021) · Advanced NanoBiomed Research · doi:10.1002/anbr.202100097 · Cited by 31
Biotin and Glutathione Targeting of Solid Nanoparticles to Cross Human Brain Endothelial Cells
Veszelka, S., Mészáros, M., Kiss, L., Kóta, Z., Páli, T., Hoyk, Z., Bozsó, Z., Fülöp, L., Toth, A., Rákhely, G., et al. (2017) · Current Pharmaceutical Design · doi:10.2174/1381612823666170727144450 · Cited by 29
Masuda, T., Hoshiyama, T., Uemura, T., Hirayama‐Kurogi, M., Ogata, S., Furukawa, A., Couraud, P., Furihata, T., Ito, S., & Ohtsuki, S. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00114 · Cited by 30
Self-citationBukchin, A., Sánchez‐Navarro, M., Carrera-Aubesart, A., Teixidò, M., Carcaboso, A. M., Giralt, E., & Sosnik, A. (2020) · Chemistry of Materials · doi:10.1021/acs.chemmater.0c01696 · Cited by 28
Endothelial-Ercc1 DNA repair deficiency provokes blood-brain barrier dysfunction
Hansen, C. E., Vacondio, D., van der Molen, L., Jüttner, A. A., Fung, W. K., Karsten, M., van het Hof, B., Fontijn, R. D., Kooij, G., Witte, M. E., et al. (2025) · Cell Death & Disease · doi:10.1038/s41419-024-07306-0 · Cited by 27
Ma, S., Liu, X., Xu, Q., & Zhang, X. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.08.006 · Cited by 27
Deepika, D., Kumar, S., Bravo, N., Esplugas, R., Capodiferro, M., Sharma, R. P., Schuhmacher, M., Grimalt, J. O., Blanco, J., & Kumar, V. (2022) · NeuroToxicology · doi:10.1016/j.neuro.2022.09.010 · Cited by 27
Co-Culture Models: Key Players in In Vitro Neurotoxicity, Neurodegeneration and BBB Modeling Studies
Monteiro, A. R., Barbosa, D. J., Remião, F., & Silva, R. (2024) · Biomedicines · doi:10.3390/biomedicines12030626 · Cited by 27
Hosseinkhani, B., Duran, G., Hoeks, C., Hermans, D., Schepers, M., Baeten, P., Poelmans, J., Coenen, B. A., Bekar, K., Pintelon, I., et al. (2023) · Fluids and Barriers of the CNS · doi:10.1186/s12987-023-00504-6 · Cited by 27
Bennett, M., Chin, A., Lee, H. J., Cestero, E. M., Strazielle, N., Ghersi‐Egea, J., Threlkeld, S. W., Schmidt, T. A., Richendrfer, H. A., Szmydynger‐Chodobska, J., et al. (2020) · Journal of Neurotrauma · doi:10.1089/neu.2020.7229 · Cited by 25
van der Wijk, A., Georgakopoulou, T., Majolée, J., van Bezu, J. S. M., van der Stoel, M. M., Hof, B. J. V. H., de Vries, H. E., Huveneers, S., Hordijk, P. L., Bakker, E. N. T. P., et al. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01071-9 · Cited by 28
Quercetin-biapigenin nanoparticles are effective to penetrate the blood–brain barrier
Oliveira, A. I., Pinho, C., Sarmento, B. F. C. C., & Dias, A. C. P. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-00917-6 · Cited by 26
Bioengineered microfluidic blood-brain barrier models in oncology research
Augustine, R., Aqel, A. H., Kalva, S. N., Joshy, K. S., Nayeem, A., & Hasan, A. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101087 · Cited by 26
Mursaleen, L., Noble, B., Somavarapu, S., & Zariwala, M. G. (2021) · Antioxidants · doi:10.3390/antiox10060887 · Cited by 26
Magrì, A., Risiglione, P., Caccamo, A., Formicola, B., Tomasello, M. F., Arrigoni, C., Zimbone, S., Guarino, F., Re, F., & Messina, A. A. (2021) · Biomedicines · doi:10.3390/biomedicines9080948 · Cited by 26
Salvador, E., Koeppl, T., Hörmann, J., Schönhärl, S., Bugaeva, P., Kessler, A. F., Burek, M., Ernestus, R., Löhr, M., & Hagemann, C. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15010185 · Cited by 28
Li, X., Cai, Q., Wilson, B. A., Fan, H., Dave, H., Giannotta, M., Bachoo, R. M., & Qin, Z. (2023) · Nanoscale · doi:10.1039/d2nr05062e · Cited by 29
Okura, T., Higuchi, K., Kitamura, A., & Deguchi, Y. (2013) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b13-00773 · Cited by 26
Sreekanthreddy, P., Gromnicova, R., Davies, H. A., Phillips, J. B., Romero, I. A., & Male, D. K. (2016) · F1000Research · doi:10.12688/f1000research.7142.2 · Cited by 26
Self-citationRaasch, M., Rennert, K., Jahn, T., Gärtner, C., Schönfelder, G., Huber, O., Seiler, A. E. M., & Mosig, A. S. (2016) · Biomicrofluidics · doi:10.1063/1.4955184 · Cited by 26
Nguyen, H., Mejia, E. M., Chang, W., Wang, Y., Watson, E. J., On, N. H., Miller, D. W., & Hatch, G. M. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13753 · Cited by 26
Hedgehog Pathway–Mediated Vascular Alterations Following Trigeminal Nerve Injury
Moreau, N., Dieb, W., Mauborgne, A., Bourgoin, S., Villanueva, L., Pohl, M., & Boucher, Y. (2016) · Journal of Dental Research · doi:10.1177/0022034516679395 · Cited by 26
Eum, S. Y., Jaraki, D., Andras, I. E., & Toborek, M. J. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.06.011 · Cited by 26
Effect of β-amyloid on blood-brain barrier properties and function
Petrushanko, I. Y., Mitkevich, V. A., & Makarov, A. А. (2023) · Biophysical Reviews · doi:10.1007/s12551-023-01052-x · Cited by 28
Chitale, S., Wu, W., Mukherjee, A., Lannon, H., Suresh, P., Nag, I., Ambrosi, C. M., Gertner, R. S., Melo, H., Powers, B., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43333-9 · Cited by 25
Bukchin, A., Sánchez‐Navarro, M., Carrera-Aubesart, A., Resa‐Pares, C., Castillo‐Ecija, H., Balaguer‐Lluna, L., Teixidò, M., Olaciregui, N. G., Giralt, E., Carcaboso, A. M., et al. (2021) · ACS Applied Nano Materials · doi:10.1021/acsanm.0c02888 · Cited by 25
Sato, N., Matsumoto, T., Kawaguchi, S., Seya, K., Matsumiya, T., Ding, J., Aizawa, T., & Imaizumi, T. (2021) · Gerodontology · doi:10.1111/ger.12545 · Cited by 25
Şen, Ö., Marino, A., Pucci, C., & Ciofani, G. (2021) · Materials Today Bio · doi:10.1016/j.mtbio.2021.100196 · Cited by 25
Metadata
- Authors
- Weksler, B., Romero, I. A., & Couraud, P.-O.
- Affiliations
- Inserm (FR)
- The Open University (GB)
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Couraud, Pierre-Olivier
- Venue
- Fluids and Barriers of the CNS
- Published
- 2013-03-26
- Volume
- 10
- Issue
- 1
- Pages
- 16-16
- ISSN
- 2045-8118 (ISSN-L)
- PMC
- PMC3623852
- OpenAlex
- W2115924220
- Cited by
- 753
- References
- 77
- Citations by year
- 2026: 45 · 2025: 70 · 2024: 76 · 2023: 75 · 2022: 68 · 2021: 83 · 2020: 58 · 2019: 63 · 2018: 36 · 2017: 53 · 2016: 42 · 2015: 36 · 2014: 36 · 2013: 10
- FWCI
- 23.39
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Fluids and Barriers of the CNS (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Open Research Online - ORO (The Open University) (acceptedVersion)
- HAL (submittedVersion, other-oa)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- blood-brain barrier, in vitro BBB model, drug transport across the blood-brain barrier, brain drug delivery, endothelial cell biology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review